CING cingulate.com: Long-Term Debt to Capital Coefficient
The market has already priced in the operational risks and liquidity shortages of Cingulate Inc. (CING) into its current valuation. The long-term accounts payable-to-equity ratio helps assess the inertia of this process, where 0.04 is recorded as the baseline value. The company's prospects rely on the development of CTX-1301 for ADHD therapy and the potential for deals with big pharma behemoths. Patent protection for its unique drug delivery method will provide Cingulate Inc. (CING) with significant pricing power.
%20Long-Term%20Debt%20to%20Capital&width=1200&height=400&colorIndex=0&v=mvrk6wqv.ssk-7as46ww&start=20220704&end=20261028&filename=GURU_Markets_-_CING_-_Cingulate-Inc._-_Long-Term-Debt-to-Capital "CING: Cingulate Corp Long-Term Debt to Capital 07/04/2022 - 10/28/2026 | 👁️GURU.Markets👁️")
Comprehensive metric breakdowns and analytics for Cingulate Inc (CING)
Cingulate Inc. is investing in CNC robotic presses to automate the production of psychotropic drugs. An analysis of the long-term debt-to-equity ratio allows for an assessment of the cost of these technological upgrades. This metric compares the volume of loans with a maturity of over one year against the value of net assets. An increase in this ratio signals a rising debt load relative to equity, which determines the company's financial stability during production scaling.